- CSCC Conference 2012
- CSCC Journal
- CSCC PDP 2012
- CSCC Membership
Québec 2012 • 17 - 20 June • Quebec Convention Centre
Québec 2012 • du 17 au 20 Juin • Centre des congrès de Québec
The Registration Form is now online!
Clinical Biochemistry, official journal of the Canadian Society of Clinical Chemists, publishes articles relating to the applications of molecular biology, biochemistry, chemistry and immunology to clinical investigation
and to the diagnosis, therapy, and monitoring of human disease.
Professional Development credits must be entered by February 28, 2012!
CSCC provides the profession with an increasingly strong and effective voice at national and international levels.
It is the only national organization that speaks out for the clinical chemist and their
rights, responsibilities and concerns.
The Salary Survey conducted in 2011 is now posted under Membership Tools. You must log in to access.
Read more| Date/Time: | Thursday May 10, 2012 830 BC/ 930 AB/ 1030 MB & SK/ 1130 ON & QC/ 1230 NS & NB/ 1300 NL |
| Topic: | Evaluation of Fetal Fibronectin Implementation in Ontario |
| Speaker: |
Dr.Sherry Perkins |
| Summary: |
Fetal Fibronectin (fFN) is an extracellular matrix glycoprotein that acts as the “glue” between the fetal sac and the uterine lining. In normal pregnancy, fFN is not detected in cervicovaginal secretions between 24 and 36 weeks gestation. fFN has been well established as a biochemical marker with a high negative predictive value for evaluation of women with suspected pre term labour at risk of pre term delivery. In January 2009 the Ministry of Health and Long Term Care in Ontario offered funding to all hospitals in Ontario to support fFN testing with the expectation that it would avoid unnecessary interventions including admissions, transfers and treatment. Changing clinical practice as a result of the implementation of a laboratory test is often challenging. The Evaluation of fFN Implementation in Ontario Study assessed the cost effectiveness of fFN and impact of province wide implementation on clinical practice. |
| Objectives: | 1) Briefly review fFN as a biomarker for risk of Pre-Term Delivery 2) Overview and present selected findings from the "Evaluation of Fetal Fibronectin Implementation in Ontario Study" |
| Complete information on the Roundtable series can be found under Conferences/Events
|
|
Committee on Nomenclature, Properties and Units (C-NPU)
Application
Deadline to apply: April 30, 2012
Committee on Clinical Laboratory Management (C-CLM)
Questionnaire
Deadline to apply: April 30, 2012
Member, Scientific Advisory Board
XIIIth International Congress of Paediatric Laboratory Medicine (ICPLM)
June 20-22, 2014 - Istanbul Turkey
To apply send a letter of interest and short 2-page CV to Head Office
Deadline to apply: May 24, 2012
Read more
Re: Electronic Health Record – Action Required
To the Canadian Clinical Chemistry Community:
In 2001 the Federal, Provincial and Territorial governments established Canada Health Infoway (Infoway) as a federally-funded, independent, not-for-profit organization, with membership consisting of Canada's 14 federal, provincial and territorial Deputy Ministers of Health. Infoway’s objective is to accelerate the use of interoperable electronic health information systems and electronic health records (EHRs) across the country. The clinical goal is that 100% of Canadians should have an EHR by 2015. To date, approximately $1.2 billion has been invested by Infoway in this venture.
Read more